Chimerix, Inc. (CMRX)

5d ago, source: Yahoo Finance

Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript February 29, 2024 Chimerix, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.23. CMRX isn’t one of the ...

Chimerix Inc CXF

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Chimerix: Q4 Earnings Snapshot

1mon ago, source: Yahoo Finance

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — Chimerix Inc. (CMRX) on Thursday reported a loss of $18.2 million in its fourth quarter. On a per-share basis, the Durham, North Carolina-based company ...

Buy Rating Affirmed for Chimerix Amid Progress in Dordaviprone’s Phase III Study and Strong Financial Outlook

1mon ago, source: Business Insider

Begin your TipRanks Premium journey today. Chimerix (CMRX) Company Description: Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of ...

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

8d ago, source:

Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced ...

Chimerix (CMRX) Earnings Dates & Reports

1mon ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Chimerix, Inc. (CMRX) interactive stock chart – Yahoo Finance

1mon ago, source: Yahoo Finance

Chimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript February 29, 2024 Chimerix, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.23. CMRX isn’t one of the 30 ...

Chimerix Appoints Marc D. Kozin to Board of Directors

1mon ago, source: ADVFN

Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the ...

Chimerix Inc CMRX

12d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Chimerix Inc.

27d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...